Retinal dystrophies are a complex set of hereditary diseases of the retina that result in the degeneration of photoreceptors. Recent studies have shown that mutations in RPE65, a gene that codes for a retinal pigment epithelium (RPE)-specific protein thought to be involved in the 11-cis-retinoid metabolism, a key process in vision, cause severe, early onset retinal dystrophy. We describe two novel missense RPE65 mutations, L22P and H68Y, in a compound heterozygote with autosomal recessive retinal dystrophy. The relatively mild phenotype associated with these mutations suggests a possible link between the severity of the disease and the type of mutations in the RPE65 gene.
Introduction
Retinal dystrophies are hereditary disorders whose common feature is the degeneration of photoreceptors, rods and/or cones. Retinitis pigmentosa (RP) is the most frequent retinal dystrophy that affects 1 in 3 to 4000 individuals in developed countries. 1, 2 Early stages of typical RP are characterised by night blindness and loss of midperipheral visual field that reflect primary rod impairment. As the disease progresses, patients lose far peripheral and central vision, eventually leading to blindness. Prominent clinical findings are the presence of bone spicule-shaped pigment in the retina and abnormal electroretinogram (ERG) responses. In addition to typical RP, there are less frequent forms of retinal dystrophy which appear to involve either primarily cones or equally rods and cones. 3, 4 Clinical varieties of retinal dyctrophy are most frequently nonsyndromic and can be inherited as autosomal dominant, autosomal recessive, X-linked or digenic diseases, with extensive allelic and nonallelic heterogeneity. 5, 6 The retinal pigment epithelium (RPE) is a single celllayered tissue in close contact with the photoreceptor outer segments which performs many functions important for the physiology of photoreceptors. Among them, the periodic phagocytosis of the outer segment tips, 7 a process whose defect leads to retinal degeneration, 8 and the metabolism of 11-cis-retinoids 9 are key processes to vision. RPE65 is a 65-kDa protein specific to the RPE. 10 While the precise role of RPE65 remains unclear, its involvement in retinoid metabolism seems certain 11 and implies a functional relationship with photoreceptor physiology. It was recently found that mutations in RPE65 cause childhood onset of severe retinal dystrophy. 12, 13 In an effort to further characterise mutations in this gene, we screened 184 unrelated patients with various types of retinal dystrophies. We report here two novel missense mutations in a compound heterozygote with autosomal recessive retinal dystrophy. 12 and 72°C for 2 min. Twelve µl of PCR products were mixed with 4 µl of stop solution (95% formamide, 10 mM NaOH, 0.05% bromophenol blue, 0.05% xylene cyanol) and denatured for 2 min at 100°C. Seven µl of each sample were then loaded on a Hydrolink MDE gel (FMC, USA) and electrophoresed at room temperature in 0.6 ϫ TBE. Gels were silver stained and air dried.
Materials and Methods

Single
Labelled SSCA To study the familial segregation of the L22P mutation, exon 2 of the RPE65 gene was 32 P-labelled and amplified by PCR as previously described.
14 Five µl of labelled PCR products were mixed with 7 µl of stop solution (95% formamide, 10 mM NaOH, 0.05% bromophenol blue, 0.05% xylene cyanol) and denatured for 2 min at 92°C. 2.8 µl of each sample were then loaded on a 5% acrylamide, 5% glycerol gel, and electrophoresed at room temperature in 0.6 ϫ TBE. Gels were dried and autoradiographed at room temperature for 6-12 h.
Direct Sequencing
Each strand of DNA was amplified by asymmetric PCR with one of the two primers reduced 50-fold in amount. The asymmetric PCR products were then filter-purified, concentrated, and 7 µl were sequenced by the dideoxynucleotide chain-termination method using sequenase (USB, USA) and 35 S dATP.
Results
Mutations in RPE65 were sought in 184 unrelated patients with various types of retinal dystrophies from whom informed consent had been obtained. For each patient the entire coding and flanking sequences 12 were amplified by polymerase chain reaction (PCR) from genomic DNA and screened using single-strand conformation analysis (SSCA). Two major DNA sequence changes were noticed. In one patient, direct sequencing of an aberrant migration pattern of the exon 9 revealed a 3-bp insertion at position 1047 (ins1047TGG) in one allele (not shown). The resulting protein should have an additional tryptophan at position 351, following tryptophan at position 350. A G to A substitution at position 1131 in exon 10 that does not change the encoded amino acid, was also found. 12 The codon duplication ins1047TGG was not found in any of the other 183 unrelated patients. However, since it did not follow the segregation of the disease in the family, we conclude that it was not pathogenic.
In a second patient, an aberrant migration pattern was detected in exon 3 (patient II 2 in Figure 1c ). Direct sequencing of this exon revealed a substitution of two consecutive nucleotides, changing G to T and C to T at cDNA positions 255 and 256, respectively (Figure 1a ). This substitution resulted in a missense mutation, H68Y. Following this finding, the 13 other exons from this patient were sequenced who was found to carry a second alteration in exon 2, substituting T to C at cDNA position 119, and resulting in a second missense mutation, L22P (Figure 1b) . The segregation of the mutations was followed in the patient's family by SSCA using Hydrolink MDE gels for H68Y and 5% acrylamide, 5% glycerol gels for L22P. This analysis revealed that H68Y and L22P were from maternal and paternal origins, respectively, confirming that the patient was a compound heterozygote (Figure 1c) . The heterozygous carriers of either one of the two mutations were asymptomatic.
Amino acid substitutions in patient II 2 are non conservative. Indeed, H68Y results in the loss of one positive charge and the substitution of a leucine to a proline at codon 22 might disorganise the C-terminal end of a hypothetical, amphipathic alpha helix. 15 Both L22 and H68 are conserved in human, 16 bovine 15 and rat [GenBank accession number AF035673] RPE65, suggesting that they may be important for the protein function. In addition, these mutations have not been found in the other 183 unrelated patients nor in 50 normal individuals, strongly supporting that they are responsible for the disease in patient II 2 .
Patient II 2 reported night blindness since early childhood and later on, in his second decade, complained of difficulties in reading, along with altered 
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F Marlhens et al t colour discrimination. At the time of the examination, aged 40 years, he was unable to find his way outside and exhibited marked peripheral field loss. Fundus examination revealed the triad, waxy pallor of optic discs, attenuated retinal vessels and bone-spicule pigment in midperipheral retina along with bilateral, extended dystrophy of the macular area. ERG responses for the scotopic system were undetectable ( < 10 µV) and profoundly affected for the photopic system (flicker responses barely detectable). His medical history and clinical findings were suggestive of a degenerative process involving both rods and cones.
Discussion
Results from this study and recent findings 12, 13 demonstrate that mutations in a RPE-specific gene lead to retinal dystrophies (Figure 2 ). Shared phenotypic features in patients with RPE65 mutations are early onset of the disease along with rapid progression of the degenerative process. The most severe clinical picture was described in two patients 12 as Leber's congenital amaurosis (LCA), a retinal dystrophy characterised by severe visual impairment at birth with extinguished ERG responses. 17 In contrast, patient II 2 described in this study exhibited a milder phenotype in childhood and a slower progression of the disease. LCA patients were compound heterozygotes for nonsense mutations implying that the truncated RPE65 products were either absent or nonfunctional. In the case of patient II 2 described in this study, the two missense mutations probably result in misfolded or functionally impaired but full-length RPE65 products. One can speculate that the level of impairment of the RPE65 protein might control the rate at which the photoreceptors degenerate. Following this hypothesis, the absence of RPE65 products would cause a massive, early degeneration of photoreceptors while substitution of amino acids would lead to a slower pace of degeneration. In fact, brief description of phenotypes with RPE65 mutations reported by Gu et al 13 suggests that premature stop codon or frameshift lead to more severe phenotype than inactivated splice site or amino acid substitutions.
Understanding of the pathogenesis of retinal dystrophy in the case of RPE65 mutations will require a knowledge of the function of the protein itself. Because of its strict specificity for the RPE and of its conservation in vertebrates, RPE65 is a good candidate for one of the few specialized functions of the RPE. Among these, the metabolic pathway that processes the alltrans-retinol to 11-cis-retinoids and that takes place in the RPE represents a key to the proper functioning of the photoreceptors. 9 Important steps of this metabolism involve a lecithin:retinol acyltransferase that esterifies dietary-derived all-trans-retinol (vitamin A), an isomerase that directly converts the retinyl ester to 11-cisretinol and an 11-cis-retinol dehydrogenase that oxidises 11-cis-retinol to 11-cis-retinal 18 which eventually associates with opsins to form photopigments. The isomerase and the 11-cis-retinol dehydrogenase are both RPE-specific microsomal enzymes, 19, 20 as is RPE65. In addition, RPE65 appears to form a protein complex with the 11-cis-dehydrogenase and with at least two unidentified products of 50 and 52 kDa. 21 These observations and the recent demonstration that addition of anti-RPE65 antibodies to RPE extracts causes a decrease in the de novo generation of 11-cisretinoids 11 suggest that RPE65 is an enzyme involved in the 11-cis-retinoid metabolism. Therefore, a defect in the RPE65 function could lead to decreased or abnormal rod and cone photopigments resulting in degeneration of photoreceptors. The medical history of patient II 2 described in this study as well as clinical findings from recent reports 12, 13 indeed suggest that both rods and cones are involved in the degenerative process. Animal models are needed to examine these hypotheses and to give further insight into the interactions between photoreceptor and RPE in retinol metabolism.
